Skip Navigation Links
Search Results
20 Projects
Fiscal Year: Active Projects, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998, 1997, 1996, 1995, 1994, 1993, 1992, 1991, 1990, 1989, 1988, 1987, 1986, 1985Organization: CASSAVA SCIENCES, INC
TActProjectYearSubPrincipal Investigator(s)/ Project Leader(s)OrganizationFiscal YearAdmin ICFunding ICFY Total Cost by ICSimilar Projects
Opioid Antagonists with Morphine for Neuropathic Pain
1TfR41ActfNS047807Projectf01YearfCASSAVA SCIENCES, INC2004NINDS
NINDS
$100,000
View View Similar Projects Similar Projectsf
Food Effect study and drug supply scale-up for PTI-125
1TfR01ActfAG067972Projectf01A1YearfCASSAVA SCIENCES, INC2021NIA
NIA
$2,710,220
View View Similar Projects Similar Projectsf
IND- and NDA-enabling toxicology studies for PTI-125, a novel small molecule for Alzheimer's disease
1TfR44ActfAG050301Projectf01YearfCASSAVA SCIENCES, INC2015NIA
NIA
$225,000
View View Similar Projects Similar Projectsf
Extending clinical trial in AD patients from 1 to 3 months
3TfR44ActfAG060878Projectf01S1YearfCASSAVA SCIENCES, INC2018NIA
NIA
$374,500
View View Similar Projects Similar Projectsf
Multiple Ascending Dose clinical trial of PTI-125, a novel AD therapeutic candidate
1TfR44ActfAG060878Projectf01YearfCASSAVA SCIENCES, INC2018NIA
NIA
$260,585
View View Similar Projects Similar Projectsf
Additional bioanalytical, dose analysis and DSMB costs for PTI-125 development
3TfR44ActfAG056166Projectf02S1YearfCASSAVA SCIENCES, INC2017NIA
NIA
$141,748
View View Similar Projects Similar Projectsf
Increasing size of Phase 2b clinical trial to 60 patients
3TfR44ActfAG060878Projectf02S1YearfCASSAVA SCIENCES, INC2020NIA
NIA
$374,500
View View Similar Projects Similar Projectsf
IND- and NDA-enabling toxicology studies for PTI-125, a novel small molecule for Alzheimer's disease
4TfR44ActfAG050301Projectf02YearfCASSAVA SCIENCES, INC2016NIA
NIA
$1,500,000
View View Similar Projects Similar Projectsf
IND, FIH study and 3-month tox for PTI-125, a novel therapeutic for Alzheimer's disease
4TfR44ActfAG056166Projectf02YearfCASSAVA SCIENCES, INC2017NIA
NIA
$1,500,000
View View Similar Projects Similar Projectsf
Open-label extension of a 3-month blinded clinical trial of PTI-125
1TfR44ActfAG065152Projectf01YearfCASSAVA SCIENCES, INC2020NIA
NIA
$2,499,896
View View Similar Projects Similar Projectsf
Multiple Ascending Dose clinical trial of PTI-125, a novel AD therapeutic candidate
4TfR44ActfAG060878Projectf02YearfCASSAVA SCIENCES, INC2019NIA
NIA
$2,896,561
View View Similar Projects Similar Projectsf
IND, FIH study and 3-month tox for PTI-125, a novel therapeutic for Alzheimer's disease
1TfR44ActfAG056166Projectf01YearfCASSAVA SCIENCES, INC2017NIA
NIA
$225,000
View View Similar Projects Similar Projectsf
Solid oral dosage form and chronic tox for PTI-125
2TfR44ActfAG056166Projectf03YearfCASSAVA SCIENCES, INC2018NIA
NIA
$2,896,320
View View Similar Projects Similar Projectsf
Additional costs related to formulation, chronic tox and general development of PTI-125
3TfR44ActfAG056166Projectf03S1YearfCASSAVA SCIENCES, INC2018NIA
NIA
$350,000
View View Similar Projects Similar Projectsf
Preformulation and formulation development of Fenrock, an Abuse-resistant Fentanyl Transdermal Patch
1TfR44ActfDA042639Projectf01A1YearfCASSAVA SCIENCES, INC2017NIDA
NIDA
$349,947
View View Similar Projects Similar Projectsf
Preformulation and formulation development of Fenrock, an Abuse-resistant Fentanyl Transdermal Patch
4TfR44ActfDA042639Projectf02YearfCASSAVA SCIENCES, INC2019NIDA
NIDA
$1,879,039
View View Similar Projects Similar Projectsf
Development of PTI-125-DX, a blood-based diagnostic for Alzheimer's disease
5TfR44ActfAG057329Projectf03YearfCASSAVA SCIENCES, INC2020NIA
NIA
$450,142
View View Similar Projects Similar Projectsf
Development of PTI-125-DX, a blood-based diagnostic for Alzheimer's disease
4TfR44ActfAG057329Projectf02YearfCASSAVA SCIENCES, INC2019NIA
NIA
$1,109,748
View View Similar Projects Similar Projectsf
Development of PTI-125-DX, a blood-based diagnostic for Alzheimer's disease
1TfR42ActfAG057329Projectf01YearfCASSAVA SCIENCES, INC2017NIA
NIA
$295,343
View View Similar Projects Similar Projectsf
Abuse-deterrent sustained-release hydromorphone
1TfR43ActfDA019739Projectf01A1YearfCASSAVA SCIENCES, INC2006NIDA
NIDA
$100,000
View View Similar Projects Similar Projectsf